2020 American Transplant Congress

Saturday, May 30, 2020

3:27pm-3:39pm

Evaluation of Intraoperative versus Extended Antibiotic Prophylaxis in Liver Transplantation

S. Hamel¹, C. Garza¹, C. Gamble², H. Boone³, L. Thomas⁴, D. L. Gorden⁵

Antimicrobial & Diagnostic Stewardship in Transplantation  •  Virtual

3:27pm-3:39pm

Factors Associated with Hepatocellular Carcinoma Understaging for Liver Transplantation, and Variation in Understaging by Transplant Center

N. Mahmud¹, M. Hoteit¹, D. Goldberg²

Liver: Hepatocellular Carcinoma and Other Malignancies I  •  Virtual

3:27pm-3:39pm

Fate of Donor-Derived Regulatory Dendritic Cells (DCreg) and Augmentation of Host Regulatory T Cells Following Their Infusion Into Prospective Living-Donor Liver Transplant Recipients

A. W. Thomson, C. Macedo, A. F. Zahorchak, X. Gu, A. Humar, F. G. Lakkis, M. A. Styn, D. M. Metes

Tolerance  •  Virtual

3:27pm-3:39pm

Frailty is Strongly Associated with Self-Reported Symptom Burden among Patients with Cirrhosis Undergoing Evaluation for Liver Transplantation

L. X. Deng, K. E. Bischoff, D. S. Kent, D. L. O’Riordan, S. Z. Pantilat, J. C. Lai

Liver: Portal Hypertension and Other Complications of Cirrhosis  •  Virtual

3:27pm-3:39pm

Frailty-Inflammatory Index & Mortality after Kidney Transplantation: Development & Validation

N. Chu, C. Haugen, D. Segev, M. McAdams-DeMarco

Kidney Psychosocial  •  Virtual

3:27pm-3:39pm

Genetic Testing of Living Related Donors for Inherited Renal Disease Improves Evaluation and Promotes Informed Choice of At-Risk Living Donors

C. P. Thomas¹, M. E. Freese¹, D. A. Katz²

Kidney Living Donor: Selection  •  Virtual

3:27pm-3:39pm

Heart Transplant Outcomes in Patients Who Receive Hepatitis B Virus-Positive Donor Hearts: A UNOS Registry Analysis

P. Genyk¹, K. Yang², R. Chand³, E. Depasquale¹

Heart Transplantation: It's All About the Outcomes  •  Virtual

3:27pm-3:39pm

Immune Checkpoint PD-L1 Pathway as an Effective Platform for Localized Immunomodulation to Attain Indefinite Allogeneic Islet Graft Survival

L. Batra¹, P. Shrestha¹, H. Zhao¹, K. B. Woodward¹, M. Tan¹, O. G. Nuno¹, A. Togay¹, M. M. Coronel², A. J. Garcia², H. Shirwan¹, E. S. Yolcu¹

Islet/Cell Transplantation  •  Virtual

3:27pm-3:39pm

Impact of CYP3A5 Phenotype on Early Time in Therapeutic Range among Pediatric Renal and Heart Transplant Recipients

A. Leino, A. Pasternak

All Organs: Pharmacogenomics / Pharmacokinetics  •  Virtual

3:27pm-3:39pm

Impact of Variation in Histological Assessments and Their Impact on Clinical Trial Enrollment and Endpoints – Preliminary Report of The Gen04 Study

W. Park¹, M. Ryan², L. Herrera Hernandez³, M. Smith², X. Geiger⁴, T. Sandor⁵, L. Cornell³, M. Stegall¹

Biomarkers, Immune Assessment and Clinical Outcomes V  •  Virtual